Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
The Securities & Exchange Commission has ordered the biotech firm BioChemics to pay more than $17 million to settle charges that it misled about 70 investors from whom it raised $9 million. According to the SEC, executives from the Danvers, Mass.-based firm falsely claimed that it had collaborations with other pharmaceutical companies and that it had drugs under Food & Drug Administration review. The SEC is separately pursuing a case against three BioChemics executives.
This article has been sent to the following recipient: